| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.05 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.52 | 0.06 |